Brasil Pharma S.A. Ord | Income Statement
Fiscal year is January-December. All values BRL Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,254
3,541
2,436
1,503
517
10
Cost of Goods Sold (COGS) incl. D&A
2,331
2,813
1,839
1,086
382
-
Gross Income
923
728
597
417
135
9
SG&A Expense
912
1,165
722
696
631
37
Unusual Expense
35
22
38
181
875
2
Non Operating Income/Expense
17
117
165
19
28
-
Interest Expense
57
110
134
138
146
9
Pretax Income
113
647
432
639
1,581
1,018
Income Tax
28
41
32
37
41
7
Equity in Affiliates
11
8
-
-
-
-
Consolidated Net Income
151
613
399
602
1,622
1,025
Net Income
151
613
399
602
1,622
1,025
Net Income After Extraordinaries
151
613
144
569
1,622
1,001
Net Income Available to Common
151
613
497
668
1,622
1,049
EPS (Basic)
29.52
98.30
90.15
6.06
14.34
9.28
Basic Shares Outstanding
5
6
7
105
113
113
EPS (Diluted)
29.52
98.30
90.15
6.06
14.34
9.28
Diluted Shares Outstanding
5
6
7
105
113
113
EBITDA
68
360
117
296
512
14
Other Operating Expense
15
12
46
61
40
-
Non-Operating Interest Income
-
8
1
2
4
1,055
About Brasil Pharma
View Profile
